These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 11811969)

  • 1. Europium-labeled epidermal growth factor and neurotensin: novel probes for receptor-binding studies.
    Mazor O; Hillairet de Boisferon M; Lombet A; Gruaz-Guyon A; Gayer B; Skrzydelsky D; Kohen F; Forgez P; Scherz A; Rostene W; Salomon Y
    Anal Biochem; 2002 Feb; 301(1):75-81. PubMed ID: 11811969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ca2+ channel blockers enhance neurotensin (NT) binding and inhibit NT-induced inositol phosphate formation in prostate cancer PC3 cells.
    Carraway RE; Gui X; Cochrane DE
    J Pharmacol Exp Ther; 2003 Nov; 307(2):640-50. PubMed ID: 14570823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical and pharmacological activities of SR 142948A, a new potent neurotensin receptor antagonist.
    Gully D; Labeeuw B; Boigegrain R; Oury-Donat F; Bachy A; Poncelet M; Steinberg R; Suaud-Chagny MF; Santucci V; Vita N; Pecceu F; Labbé-Jullié C; Kitabgi P; Soubrié P; Le Fur G; Maffrand JP
    J Pharmacol Exp Ther; 1997 Feb; 280(2):802-12. PubMed ID: 9023294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell cycle variation in 125I-labeled epidermal growth factor binding in chemically transformed cells.
    Robinson RA; Branum EL; Volkenant ME; Moses HL
    Cancer Res; 1982 Jul; 42(7):2633-8. PubMed ID: 6979383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melatonin and prostate cancer cell proliferation: interplay with castration, epidermal growth factor, and androgen sensitivity.
    Siu SW; Lau KW; Tam PC; Shiu SY
    Prostate; 2002 Jul; 52(2):106-22. PubMed ID: 12111702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel bioactive and stable neurotensin peptide analogues capable of delivering radiopharmaceuticals and molecular beacons to tumors.
    Achilefu S; Srinivasan A; Schmidt MA; Jimenez HN; Bugaj JE; Erion JL
    J Med Chem; 2003 Jul; 46(15):3403-11. PubMed ID: 12852770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo and in vitro structure-activity studies with peptide and pseudopeptide neurotensin analogs suggest the existence of distinct central neurotensin receptor subtypes.
    Labbé-Jullié C; Dubuc I; Brouard A; Doulut S; Bourdel E; Pelaprat D; Mazella J; Martinez J; Rostène W; Costentin J
    J Pharmacol Exp Ther; 1994 Jan; 268(1):328-36. PubMed ID: 8301574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double-stabilized neurotensin analogues as potential radiopharmaceuticals for NTR-positive tumors.
    García-Garayoa E; Maes V; Bläuenstein P; Blanc A; Hohn A; Tourwé D; Schubiger PA
    Nucl Med Biol; 2006 May; 33(4):495-503. PubMed ID: 16720241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurotensin stimulates protein kinase C-dependent mitogenic signaling in human pancreatic carcinoma cell line PANC-1.
    Guha S; Lunn JA; Santiskulvong C; Rozengurt E
    Cancer Res; 2003 May; 63(10):2379-87. PubMed ID: 12750255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Europium-labeled melanin-concentrating hormone analogues: ligands for measuring binding to melanin-concentrating hormone receptors 1 and 2.
    Gao X; Hsu CK; Heinz LJ; Morin J; Shi Y; Shukla NK; Smiley DL; Xu J; Zhong B; Slieker LJ
    Anal Biochem; 2004 May; 328(2):187-95. PubMed ID: 15113696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sarcoma growth factor (SGF): specific binding to epidermal growth factor (EGF) membrane receptors.
    De Larco JE; Todaro GJ
    J Cell Physiol; 1980 Feb; 102(2):267-77. PubMed ID: 6246130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the epidermal growth factor receptor in human meningioma.
    Weisman AS; Raguet SS; Kelly PA
    Cancer Res; 1987 Apr; 47(8):2172-6. PubMed ID: 3493842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solid-phase synthesis of europium-labeled human INSL3 as a novel probe for the study of ligand-receptor interactions.
    Shabanpoor F; Hughes RA; Bathgate RA; Zhang S; Scanlon DB; Lin F; Hossain MA; Separovic F; Wade JD
    Bioconjug Chem; 2008 Jul; 19(7):1456-63. PubMed ID: 18529069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The chemical synthesis and binding affinity to the EGF receptor of the EGF-like domain of heparin-binding EGF-like growth factor (HB-EGF).
    Shin SY; Yokoyama T; Takenouchi T; Munekata E
    J Pept Sci; 2003 Apr; 9(4):244-50. PubMed ID: 12725245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockade of epidermal growth factor receptor signaling leads to inhibition of renal cell carcinoma growth in the bone of nude mice.
    Weber KL; Doucet M; Price JE; Baker C; Kim SJ; Fidler IJ
    Cancer Res; 2003 Jun; 63(11):2940-7. PubMed ID: 12782601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-affinity neurotensin receptor (NTS2) signaling: internalization-dependent activation of extracellular signal-regulated kinases 1/2.
    Gendron L; Perron A; Payet MD; Gallo-Payet N; Sarret P; Beaudet A
    Mol Pharmacol; 2004 Dec; 66(6):1421-30. PubMed ID: 15361549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coiled-coil tag--probe system for quick labeling of membrane receptors in living cell.
    Yano Y; Yano A; Oishi S; Sugimoto Y; Tsujimoto G; Fujii N; Matsuzaki K
    ACS Chem Biol; 2008 Jun; 3(6):341-5. PubMed ID: 18533657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The bioactivity and receptor affinity of recombinant tagged EGF designed for tissue engineering applications is defined by the nature and position of the tags.
    Boucher C; St-Laurent G; Loignon M; Jolicoeur M; De Crescenzo G; Durocher Y
    Tissue Eng Part A; 2008 Dec; 14(12):2069-77. PubMed ID: 18652537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lanthanide-based time-resolved fluorescence of in cyto ligand-receptor interactions.
    Handl HL; Vagner J; Yamamura HI; Hruby VJ; Gillies RJ
    Anal Biochem; 2004 Jul; 330(2):242-50. PubMed ID: 15203329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controlled proteolysis of EGF receptors: evidence for transmembrane distribution of the EGF binding and phosphate acceptor sites.
    Linsley PS; Fox CF
    J Supramol Struct; 1980; 14(4):461-71. PubMed ID: 6264233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.